123 related articles for article (PubMed ID: 38368241)
1. Corrigendum to "Gypenoside XLIX attenuates sepsis-induced splenic injury through inhibiting inflammation and oxidative stress" [Int. Immunopharmacol. 127 (2024) 111420].
Xu B; Yang R; Qiang J; Xu X; Zhou M; Ji X; Lu Y; Dong Z
Int Immunopharmacol; 2024 Apr; 131():111694. PubMed ID: 38368241
[No Abstract] [Full Text] [Related]
2. Gypenoside XLIX attenuates sepsis-induced splenic injury through inhibiting inflammation and oxidative stress.
Xu B; Yang R; Qiang J; Xu X; Zhou M; Ji X; Lu Y; Dong Z
Int Immunopharmacol; 2024 Jan; 127():111420. PubMed ID: 38142642
[TBL] [Abstract][Full Text] [Related]
3. Gypenoside XLIX, a naturally occurring PPAR-alpha activator, inhibits cytokine-induced vascular cell adhesion molecule-1 expression and activity in human endothelial cells.
Huang TH; Tran VH; Roufogalis BD; Li Y
Eur J Pharmacol; 2007 Jun; 565(1-3):158-65. PubMed ID: 17434475
[TBL] [Abstract][Full Text] [Related]
4. Determination of Gypenoside A and Gypenoside XLIX in Rat Plasma by UPLC-MS/MS and Applied to the Pharmacokinetics and Bioavailability.
He Y; Liang Q; Luo L; He Y; Huang X; Wen C
Int J Anal Chem; 2022; 2022():6734408. PubMed ID: 35992562
[TBL] [Abstract][Full Text] [Related]
5. Corrigendum to "Methylallyl sulfone attenuates inflammation, oxidative stress and lung injury induced by cigarette smoke extract in mice and RAW264.7 cells" Int Immunopharmacol, volume 59, 2018, 369-374.
Li A; Liu Y; Zhu X; Sun X; Feng X; Li D; Zhang J; Zhu M; Zhao Z
Int Immunopharmacol; 2019 Jul; 72():522. PubMed ID: 30922802
[No Abstract] [Full Text] [Related]
6. Gypenoside XLIX protects against acute kidney injury by suppressing IGFBP7/IGF1R-mediated programmed cell death and inflammation.
Yang Q; Zang HM; Xing T; Zhang SF; Li C; Zhang Y; Dong YH; Hu XW; Yu JT; Wen JG; Jin J; Li J; Zhao R; Ma TT; Meng XM
Phytomedicine; 2021 May; 85():153541. PubMed ID: 33773190
[TBL] [Abstract][Full Text] [Related]
7. An effective and high-throughput sample preparation method involving demalonylation followed by an ultrahigh-performance liquid chromatography-charged aerosol detector for analyzing gypenoside XLIX and gypenoside A in Gynostemma longipes.
Li G; Lu PX; Liang HZ; Zheng W; Chen XJ; Zhang J; Song J; Yang G; Wang YX; Zhang T; Guo BL; Ma BP
J Pharm Biomed Anal; 2023 Jun; 230():115393. PubMed ID: 37062206
[TBL] [Abstract][Full Text] [Related]
8. Enzymatic Biotransformation of Gypenoside XLIX into Gylongiposide I and Their Antiviral Roles against Enterovirus 71 In Vitro.
Zhao H; Jiao W; Xiu Y; Zhou K; Zhong P; Wang N; Yu S
Molecules; 2022 Jun; 27(13):. PubMed ID: 35807341
[TBL] [Abstract][Full Text] [Related]
9. Development of a targeted method for quantification of gypenoside XLIX in rat plasma, using SPE and LC-MS/MS.
Guo S; Sui C; Ma Y
Biomed Chromatogr; 2017 Jun; 31(6):. PubMed ID: 27859537
[TBL] [Abstract][Full Text] [Related]
10. Corrigendum to "Curcumin attenuates sepsis-induced acute organ dysfunction by preventing inflammation and enhancing the suppressive function of Tregs" [Int. Immunopharmacol. 61 (2018) 1-7].
Chen L; Lu Y; Zhao L; Hu L; Qiu Q; Zhang Z; Li M; Hong G; Wu B; Zhao G; Lu Z
Int Immunopharmacol; 2024 Jun; ():112471. PubMed ID: 38879417
[No Abstract] [Full Text] [Related]
11. Corrigendum to "Ghrelin attenuates secondary brain injury following intracerebral hemorrhage by inhibiting NLRP3 inflammasome activation and promoting Nrf2/ARE signaling pathway in mice" [Int. Immunopharmacol. 79 (2020) 106180].
Cheng Y; Chen B; Xie W; Chen Z; Yang G; Cai Y; Shang H; Zhao W
Int Immunopharmacol; 2020 Jul; 84():106461. PubMed ID: 32278662
[No Abstract] [Full Text] [Related]
12. Corrigendum to "Paeonol derivative-6 attenuates inflammation by activating ZEB2 in acute liver injury" [Int. Immunopharmacol. 91 (2021) 107235].
Yang J; Xu L; Wu M; Fang H; Lu Y; Shi C; Wang Y; Li Z; Zhang L; Zhang L
Int Immunopharmacol; 2021 May; 94():107410. PubMed ID: 33578262
[No Abstract] [Full Text] [Related]
13. Corrigendum to "Exosomal miR-127-5p from BMSCs alleviated sepsis-related acute lung injury by inhibiting neutrophil extracellular trap formation" [Int. Immunopharmacol. 123 (2023) 110759].
Zheng XL; Gu WJ; Zhang F; Zhao FZ; Li LZ; Huang HY; Li LJ; Yi YH; Yin HY; Xu J
Int Immunopharmacol; 2023 Dec; 125(Pt A):111076. PubMed ID: 37866976
[No Abstract] [Full Text] [Related]
14. Corrigendum to "MEGF6 prevents sepsis-induced acute lung injury in mice" [Int. Immunopharmacol. 123 (2023) 110727].
Liang H; Liu G; Zeng W; Fan Q; Nie Z; Hu H; Zhang R; Xie S
Int Immunopharmacol; 2024 May; 133():111787. PubMed ID: 38641473
[No Abstract] [Full Text] [Related]
15. Corrigendum to "Sophoricoside attenuates lipopolysaccharide-induced acute lung injury by activating the AMPK/Nrf2 signaling axis" [Int. Immunopharmacol. 90 (2021) 107187].
Wu YX; Zeng S; Wan BB; Wang YY; Sun HX; Liu G; Gao ZQ; Chen D; Chen YQ; Lu MD; Pang QF
Int Immunopharmacol; 2023 Nov; 124(Pt A):111008. PubMed ID: 37806791
[No Abstract] [Full Text] [Related]
16. Corrigendum to "Molsidomine alleviates acetic acid-induced colitis in rats by reducing oxidative stress, inflammation and apoptosis" [Int. Immunopharmacol. 99 (2021) 108005].
Mohamed NI; Suddek GM; El-Kashef DH
Int Immunopharmacol; 2022 Apr; 105():108575. PubMed ID: 35115257
[No Abstract] [Full Text] [Related]
17. Corrigendum to "Inhibition of MRP4 alleviates sepsis-induced acute lung injury in rats" [Int. Immunopharmacol. 72 (2019) 211-217].
Xia W; Zhang H; Pan Z; Li G; Zhou Q; Hu D; Liu Y
Int Immunopharmacol; 2023 Sep; 122():110699. PubMed ID: 37500384
[No Abstract] [Full Text] [Related]
18. Corrigendum to "Sodium houttuyfonate enhances the intestinal barrier and attenuates inflammation induced by Salmonella typhimurium through the NF-κB pathway in mice" [Int. Immunopharmacol. 89 (2020) 107058].
Zhang L; Lv H; Li Y; Dong N; Bi C; Shan A; Wu Z; Shi B
Int Immunopharmacol; 2021 Mar; 92():107351. PubMed ID: 33444920
[No Abstract] [Full Text] [Related]
19. Gypenoside XLIX isolated from Gynostemma pentaphyllum inhibits nuclear factor-kappaB activation via a PPAR-alpha-dependent pathway.
Huang TH; Li Y; Razmovski-Naumovski V; Tran VH; Li GQ; Duke CC; Roufogalis BD
J Biomed Sci; 2006 Jul; 13(4):535-48. PubMed ID: 16525884
[TBL] [Abstract][Full Text] [Related]
20. Corrigendum to "Antidepressant-like effects of helicid on a chronic unpredictable mild stress-induced depression rat model: Inhibiting the IKK/IκBα/NF-κB pathway through NCALD to reduce inflammation" [Int. Immunopharmacol. 93 (2021) 107165].
Zhang YX; Zhang XT; Li HJ; Zhou TF; Zhou AC; Zhong ZL; Liu YH; Yuan LL; Zhu HY; Luan D; Tong JC
Int Immunopharmacol; 2023 Aug; 121():110611. PubMed ID: 37468398
[No Abstract] [Full Text] [Related]
[Next] [New Search]
